Fair Value of Financial Instruments (Tables)

12 Months Ended

Jun. 30, 2014

Fair Value Disclosures [Abstract]

Short-term Investments and Financial Instruments

The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2014:

	Total		Quoted prices  in active markets (Level  1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion	$	14,044	$	14,044	$	—	$	—
Forward foreign currency exchange contracts	65		—		65		—
Total assets at fair value	$	14,109	$	14,044	$	65	$	—
Liabilities:
Deferred compensation plan investments, current and non-current portion	$	14,044	$	14,044	$	—	$	—
Forward foreign currency exchange contracts	119		—		119		—
Liability for contingent consideration, current and non-current	11,107		—		—		11,107
Total liabilities at fair value	$	25,270	$	14,044	$	119	$	11,107

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2013:

	Total		Quoted prices  in active markets (Level  1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion	$	13,752	$	13,752	$	—	$	—
Forward foreign currency exchange contracts	308		—		308		—
Total assets at fair value	$	14,060	$	13,752	$	308	$	—
Liabilities:
Deferred compensation plan investments, current and non-current portion	$	13,752	$	13,752	$	—	$	—
Forward foreign currency exchange contracts	34		—		34		—
Liability for contingent consideration, current and non-current	12,545		—		—		12,545
Total liabilities at fair value	$	26,331	$	13,752	$	34	$	12,545

Fair Value, Business Acquisition, Liability for Contingent Consideration

The table below provides a summary of the changes in fair value of the Company’s only financial asset or liability, the contingent consideration for the CDC earnout that is measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the year ended June 30, 2014 and 2013:

	Contingent Consideration for the Year Ended			Contingent Consideration for the Year Ended
	June 30, 2014			June 30, 2013
	(in thousands)
Fair value at beginning of period	$	12,545		$	16,653
Payments	(3,810		)	(4,777		)
Change in fair value	2,311			1,843
Fluctuation due to foreign currency exchange	61			(1,174		)
Fair value at end of period	$	11,107		$	12,545